Rockwell Medical (RMTI) Other Non-Current Liabilities (2010 - 2025)
Rockwell Medical's (RMTI) quarterly Other Non-Current Liabilities came in at $500000.0 in Q1 2025, up 3471.43% YoY from $14000.0 in Q1 2024, and down 50.0% on a QoQ basis from $1.0 million in Q4 2024.
Rockwell Medical (RMTI) Other Non-Current Liabilities (2010 - 2025) Analysis & Trends
Rockwell Medical (RMTI) has 10 years of Other Non-Current Liabilities data on file, last reported at $500000.0 in Q1 2025.
- Quarterly Other Non-Current Liabilities rose 3471.43% year-over-year to $500000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $500000.0 (up 3471.43% YoY) and the FY2024 annual result came in at $1.0 million, up 7042.86% from the prior year.
- Other Non-Current Liabilities fell to $500000.0 in Q1 2025, from $1.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $2.5 million in Q3 2023 to a low of $14000.0 in Q4 2021.
- A 5-year average of $318461.5 and a median of $14000.0 in 2021 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities jumped 17757.14% — and 2024, when it slumped 99.44%.
- Tracing RMTI's Other Non-Current Liabilities over 5 years: stood at $14000.0 in 2021, then changed by 0.0% to $14000.0 in 2022, then changed by 0.0% to $14000.0 in 2023, then jumped by 7042.86% to $1.0 million in 2024, then slumped by 50.0% to $500000.0 in 2025.
- The last three Other Non-Current Liabilities figures came in at $500000.0 (Q1 2025), $1.0 million (Q4 2024), and $14000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Rockwell Medical | 30.62 Mn | 5.82 Mn | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | 2.50 Mn |
| Jun 30, 2023 | 14,000.00 |
| Mar 31, 2023 | 14,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Sep 30, 2014 | 4.23 Mn |
| Jun 30, 2014 | 4.23 Mn |
| Mar 31, 2014 | 4.23 Mn |
| Dec 31, 2013 | 4.90 Mn |
| Sep 30, 2013 | 5.16 Mn |
| Jun 30, 2013 | 7.79 Mn |
| Mar 31, 2013 | 8.00 Mn |